Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it ...

Large U.S. companies expect their health care costs to rise a median of 9% in 2026, according to a survey by the Business Group on Health. That is up from an expected 8% jump in 2025 and the steepest ...

Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...

It’s a grand slam partnership for telehealth provider Ro. World renowned tennis star Serena Willams is partnering with the brand as its newest ambassador to talk about her journey with GLP-1s.

Gary Ellsworth, Head of North America Alliance Management, IQVIA shares insight on key trends driving outsourcing in today’s ...